Tuberculosis–HIV co-infection in an era of complex, rapid new drug development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tuberculosis–HIV co-infection in an era of complex, rapid new drug development

Published:2023-10-01 Issue:12 Volume:37 Page:1897-1898
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Venter Francois¹²,Niyongabo Bienvenu³

Affiliation:

1. Ezintsha, School of Clinical Medicine, University of the Witwatersrand, Johannesburg

2. Department of Public Health Medicine, School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa

3. USAID-Rwanda Integrated Health Systems Activity, Kigali, Rwanda.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference10 articles.

1. Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries;Maartens;Antivir Ther,2009

2. Management of active tuberculosis in adults with HIV;Meintjes;Lancet HIV,2019

3. The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?;Vitoria;AIDS,2018

4. Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countries;De Castro;AIDS,2023

5. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, noninferiority, randomised, phase 3 trial;De Castro;Lancet Infect Dis,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP